As more than More than 100 million U.S. adults are now living with diabetes or prediabetes and the great responsibility that comes with that. It is essential to look at how the healthcare industry is changing to adapt to this demand. People living with diabetes are lacking in access to the critical supplies needed to manage and maintain this illness. People living with diabetes are also without access to information necessary to provide proper accommodations.
The cost of insulin continues to be a problem for those affected by diabetes. According to recent studies by the American Diabetes Association Overall, 39% of insulin users experienced an increase in the amount they pay for insulin over the past year. Even those with excellent health coverage are having issues paying for there testing supplies.
According to a study by the World Health Organization Insulin availability in primary care institutions was very low (10% to 20%). No intermediate-acting human insulin was available in primary care institutions. Overall, the availability of insulin in private pharmacies ranged from 13% for prandial (10% short-acting and 10% rapid-acting) to 33% for pre-mixed (27% human and 20% analog).
A recent AADE “secret shopper” survey revealed that currently, most mail-order suppliers do not carry 50% of the blood glucose models covered by the Medicare market shares of DTS, nor was factual information provided about available inventory. The result of the lack of access was the failure to receive trusted supplies and training to use DTS. In some cases.
Many people that are dealing with diabetes are unaware that they can receive specific workplace accommodations to check insulin etc. According to The Americans with Disabilities Act individuals with diabetes can request accommodations without fear of losing employment.
Diabetes is a widely accepted illness. However, there is still a stigma surrounding Type 2 diabetes. According to a study conducted by the American Diabetes Association. A more significant percentage of those that participated in the study with type 1 diabetes reported diabetes stigma than those with type 2 diabetes 76 vs. 52%
What we can see from looking at these statistics is that the healthcare industry has a long way to come in addressing the needs of those that live diabetes. In all categories, those living with diabetes can use more access to critical supplies and information to live a better life.